Clinical trial
Prospective Observation of Cardiac Safety With Proteasome Inhibition
NCT02178579 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observation of Cardiac Safety With Proteasome Inhibition
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- July 15, 2019
- Enrollment
- 95 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.